Bylvay
Product Images NDC 74528-020

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bylvay (NDC 74528-020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Albireo Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bylvay 01)

Chemical structure of the active ingredient in BYLVAY by Albireo Pharma, Inc., showing the molecular arrangement including hydroxyl, amide, sulfonamide, and methylthio functional groups along with 1.5 molecules of water of hydration.*

FDA Label Image

Figure 1 (Bylvay 02)

Line chart comparing scratching scores over six months for placebo, Odevixibat 40 mcg/kg/day, and Odevixibat 120 mcg/kg/day groups. The y-axis shows the scratching score, and the x-axis shows time in months. Both Odevixibat doses show a decrease in scratching scores over time, while the placebo group remains relatively stable.*

FDA Label Image

Figure A (Bylvay 03)

Illustration showing hands squeezing a small device or component with arrows pointing inward from both sides, indicating to press or compress the blue section. The image likely demonstrates a step in the use or activation of a BYLVAY product component.*

FDA Label Image

Figure B (Bylvay 04)

An instructional illustration showing two hands peeling apart a blue capsule, releasing small round pellets or beads onto a surface, likely demonstrating capsule opening and pellet content use.*

FDA Label Image

Figure C (Bylvay 05)

An instructional illustration showing two hands breaking apart a blue capsule over a surface with scattered granules, demonstrating capsule opening or content emptying.*

FDA Label Image

Figure D (Bylvay 06)

An instructional illustration showing a hand stirring a substance in a bowl with a spoon. The image includes a curved arrow indicating a circular stirring motion around the bowl.*

FDA Label Image

Principal Display Panel (200 mcg Capsule Bottle Carton)

Packaging label for BYLVAY (odevixibat) oral pellets, 200 mcg strength, containing 30 capsules. The label shows the drug's proprietary name, active ingredient, strength, dosage form, and quantity. It includes storage instructions and is manufactured and distributed by Albireo Pharma, Inc. The label also features the NDC code 74528-020-01 and states origin as India.*

FDA Label Image

Principal Display Panel (400 mcg Capsule Bottle Carton)

Outer carton packaging label for BYLVAY capsules containing 400 mcg of odevixibat. The label shows the brand name BYLVAY, active ingredient odevixibat, and dosage strength of 400 mcg. It indicates 30 capsules per package, manufactured and distributed by Albireo Pharma, Inc., with product origin noted as India. Storage instructions and barcode are also visible on the label.*

FDA Label Image

Principal Display Panel (600 mcg Capsule Bottle Carton)

Package label for BYLVAY (odevixibat) oral pellets, 600 mcg strength, in a 30-capsule bottle. Label shows the Albireo Pharma, Inc. logo and states the product is manufactured and distributed by Albireo Pharma, located in Boston, MA, with origin in India. Storage conditions and dosage advising to see prescribing information are included. The label also features a barcode and a 2D code.*

FDA Label Image

Principal Display Panel (1,200 mcg Capsule Bottle Carton)

Packaging label for BYLVAY (odevixibat) capsules containing 1,200 mcg per capsule. The label indicates a 30 capsule count, manufactured and distributed by Albireo Pharma, Inc. The storage instructions and dosage recommendation references prescribing information. The label includes a barcode, 2D code placeholder, and origin noted as India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.